Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
Collaborative Project on Potential Serum Markers for Malignant Melanoma, Metastatic Breast, Advanced Lung Pancreatic Carcinoma and Colorectal Cancer
2 other identifiers
observational
803
1 country
13
Brief Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in peptides and proteins and identify biomarkers related to cancer. PURPOSE: This research study is looking at blood samples from patients with malignant melanoma, metastatic breast cancer, advanced lung cancer, pancreatic cancer, or colorectal cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2008
Longer than P75 for all trials
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 9, 2009
CompletedFirst Posted
Study publicly available on registry
September 10, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2017
CompletedMay 24, 2017
May 1, 2017
7.3 years
September 9, 2009
May 23, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Detection of peptide and protein markers in serum
Ongoing
Secondary Outcomes (1)
Identification of the protein/peptide involved
Ongoing
Study Arms (5)
Breast
Lung
Melanoma
Pancreatic
Colorectal
Eligibility Criteria
5 different tumour types
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (13)
Cork University Hospital
Cork, Ireland
Mercy University Hospital
Cork, Ireland
Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital
Dublin, 24, Ireland
St. Vincent's University Hospital
Dublin, 4, Ireland
Mater Misericordiae University Hospital
Dublin, 7, Ireland
St. James's Hospital
Dublin, 8, Ireland
Beaumont Hospital
Dublin, 9, Ireland
Mater Private Hospital
Dublin, Ireland
St Luke's Hospital
Dublin, Ireland
University College Hospital
Galway, Ireland
Letterkenny General Hospital
Letterkenny, Ireland
Mid-Western Cancer Centre at Mid-Western Regional Hospital
Limerick, 0009, Ireland
Waterford Regional Hospital
Waterford, Ireland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martin Clynes
National Institute for Cellular Biotechnology at Dublin City University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2009
First Posted
September 10, 2009
Study Start
August 1, 2008
Primary Completion
December 1, 2015
Study Completion
January 1, 2017
Last Updated
May 24, 2017
Record last verified: 2017-05